Oxford Vaccine Shot
-
{
- All
- News
- Videos
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
-
How to Download COVID-19 Vaccine Certificate
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
Oxford Study Shows AstraZeneca Shot Works Against Brazil Strain: Report
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday.
-
Growing Evidence On Oxford Shot Should Guide Other Countries, Vaccine Chief Says
Real-world data on the effectiveness of Oxford and AstraZeneca's COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.
-
"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield
Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.
-
Sri Lanka Puts China Vaccine On Hold, Will Use India-Made Shot
Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.
-
Myanmar Launches Covid Vaccination Drive, Prioritises Healthcare Workers
Myanmar launched a COVID-19 vaccination programme on Wednesday, with healthcare staff and volunteer medical workers the first to receive shots of the AstraZeneca and Oxford University vaccine donated by India.
-
Coronavirus Vaccines Explained: How The Two Shots Launching In India Work
India on Saturday will launch one of the world's biggest vaccination programmes with vaccines manufactured in the country - one developed by Oxford University and AstraZeneca, the other by Bharat Biotech International with a state-run institute.
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Clotting From Covid Shots Is Rare But "Potentially Devastating": Study
Researchers say they're making progress in understanding a clotting disorder linked to Covid-19 vaccines that they describe as very rare but potentially "devastating."
-
Third AstraZeneca Shot, 6 Months After Second, Works Great: Study
Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
-
How to Download COVID-19 Vaccine Certificate
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
Oxford Study Shows AstraZeneca Shot Works Against Brazil Strain: Report
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday.
-
Growing Evidence On Oxford Shot Should Guide Other Countries, Vaccine Chief Says
Real-world data on the effectiveness of Oxford and AstraZeneca's COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.
-
"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield
Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.
-
Sri Lanka Puts China Vaccine On Hold, Will Use India-Made Shot
Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.
-
Myanmar Launches Covid Vaccination Drive, Prioritises Healthcare Workers
Myanmar launched a COVID-19 vaccination programme on Wednesday, with healthcare staff and volunteer medical workers the first to receive shots of the AstraZeneca and Oxford University vaccine donated by India.
-
Coronavirus Vaccines Explained: How The Two Shots Launching In India Work
India on Saturday will launch one of the world's biggest vaccination programmes with vaccines manufactured in the country - one developed by Oxford University and AstraZeneca, the other by Bharat Biotech International with a state-run institute.
